The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1640
ISSUE1640
December 27, 2021
Xywav - A Mixed-Salt Oxybate Oral Solution for Idiopathic Hypersomnia
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Xywav - A Mixed-Salt Oxybate Oral Solution for Idiopathic Hypersomnia
December 27, 2021 (Issue: 1640)
Xywav (Jazz), an oral solution that contains calcium,
magnesium, potassium, and sodium oxybates, has
been approved by the FDA for treatment of idiopathic
hypersomnia in adults. It is the first drug to be
approved in the US for this indication....more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.